Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Enzyme therapy for functional bowel disease-like post-prandial distress
For clinicians and informed customers, that means improved bioavailability, fewer rapid spikes and longer window of benefit compared with direct LArginine dosing
Description A triple receptor agonist studied in controlled laboratory settings across GLP-1, GIP, and glucagon receptor signaling pathways
UGDH served as a positive control
That sounds reasonable on paper
US$ 25.50
US$ 24.01
US$ 20.58
US$ 22.95
US$ 24.92
US$ 20.98
US$ 26.36
US$ 21.24
US$ 27.19
